Levothyroxine Sodium/Liothyronine sodium

N/A

Report date: 2025/07/30 14:54:04

Base Information

Drug NameLevothyroxine Sodium/Liothyronine sodium
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor agonistsThyroid hormone receptor beta-1 agonistsThyroid hormone receptor alpha agonists
TargetsThyroid hormone receptorThyroid hormone receptor betaThyroid hormone receptor alpha
Therapy Area/IndicationsHypothyroidism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsYes Levothyroxine SodiumLiothyronine sodium
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDorsa Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesDorsa Pharmaceutical Company
Inactive CompaniesN/A
Active IndicationsHypothyroidism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A